Targeting barriers to wider use of trimodality therapy in localized muscle invasive bladder cancer

Leslie Ballas; Parminder Singh; Seth P. Lerner

doi:10.1016/j.urolonc.2020.10.005

Targeting barriers to wider use of trimodality therapy in localized muscle invasive bladder cancer

Leslie Ballas
, Parminder Singh
, Seth P. Lerner

Medicine

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Abstract

Radical cystectomy with bilateral pelvic lymphadenectomy and trimodality bladder-sparing therapy or TMT, are both curative options for patients with nonmetastatic muscle invasive bladder cancer. Patients should be afforded the opportunity for a multidisciplinary evaluation with equipoise in discussing these options for eligible patients. We discuss the barriers to broader acceptance and utilization of TMT and encourage support of clinical trials of TMT.

Original language	English (US)
Pages (from-to)	35-38
Number of pages	4
Journal	Urologic Oncology: Seminars and Original Investigations
Volume	41
Issue number	1
DOIs	https://doi.org/10.1016/j.urolonc.2020.10.005
State	Published - Jan 2023

Keywords

Barriers
Bladder cancer
Chemoradiation
Radical cystectomy
Trimodality therapy

ASJC Scopus subject areas

Oncology
Urology

Access to Document

10.1016/j.urolonc.2020.10.005

Cite this

@article{cac86f1f9cb94ffb84bea7258e55d3f5,

title = "Targeting barriers to wider use of trimodality therapy in localized muscle invasive bladder cancer",

abstract = "Radical cystectomy with bilateral pelvic lymphadenectomy and trimodality bladder-sparing therapy or TMT, are both curative options for patients with nonmetastatic muscle invasive bladder cancer. Patients should be afforded the opportunity for a multidisciplinary evaluation with equipoise in discussing these options for eligible patients. We discuss the barriers to broader acceptance and utilization of TMT and encourage support of clinical trials of TMT.",

keywords = "Barriers, Bladder cancer, Chemoradiation, Radical cystectomy, Trimodality therapy",

author = "Leslie Ballas and Parminder Singh and Lerner, \{Seth P.\}",

note = "Publisher Copyright: {\textcopyright} 2020 Elsevier Inc.",

year = "2023",

month = jan,

doi = "10.1016/j.urolonc.2020.10.005",

language = "English (US)",

volume = "41",

pages = "35--38",

journal = "Urologic Oncology: Seminars and Original Investigations",

issn = "1078-1439",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - Targeting barriers to wider use of trimodality therapy in localized muscle invasive bladder cancer

AU - Ballas, Leslie

AU - Singh, Parminder

AU - Lerner, Seth P.

PY - 2023/1

Y1 - 2023/1

N2 - Radical cystectomy with bilateral pelvic lymphadenectomy and trimodality bladder-sparing therapy or TMT, are both curative options for patients with nonmetastatic muscle invasive bladder cancer. Patients should be afforded the opportunity for a multidisciplinary evaluation with equipoise in discussing these options for eligible patients. We discuss the barriers to broader acceptance and utilization of TMT and encourage support of clinical trials of TMT.

AB - Radical cystectomy with bilateral pelvic lymphadenectomy and trimodality bladder-sparing therapy or TMT, are both curative options for patients with nonmetastatic muscle invasive bladder cancer. Patients should be afforded the opportunity for a multidisciplinary evaluation with equipoise in discussing these options for eligible patients. We discuss the barriers to broader acceptance and utilization of TMT and encourage support of clinical trials of TMT.

KW - Barriers

KW - Bladder cancer

KW - Chemoradiation

KW - Radical cystectomy

KW - Trimodality therapy

UR - https://www.scopus.com/pages/publications/85095745674

UR - https://www.scopus.com/pages/publications/85095745674#tab=citedBy

U2 - 10.1016/j.urolonc.2020.10.005

DO - 10.1016/j.urolonc.2020.10.005

M3 - Review article

C2 - 33153882

AN - SCOPUS:85095745674

SN - 1078-1439

VL - 41

SP - 35

EP - 38

JO - Urologic Oncology: Seminars and Original Investigations

JF - Urologic Oncology: Seminars and Original Investigations

IS - 1

ER -

Targeting barriers to wider use of trimodality therapy in localized muscle invasive bladder cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this